Lee Darlene, Erande Ashwini, Christodoulou Georgia, Malik Shaista
Susan Samueli Integrative Health Institute, University of California at Irvine, Irvine, California, USA.
Stress Health. 2024 Dec;40(6):e3502. doi: 10.1002/smi.3502. Epub 2024 Nov 8.
Psychological stress among frontline healthcare workers (HCWs) increased during the COVID-19 pandemic, elevating mental health risks. Heart rate variability biofeedback (HRV-BF) is an evidence-based intervention with potential to reduce psychological burden on frontline HCWs; however, no studies have examined its use among this population since the pandemic began. We designed a trial to assess the effects of a brief HRV-BF intervention delivered via telemedicine on measures of anxiety, depression and stress, and heart rate variability, compared to an in-person intervention. We hypothesised that the telemedicine intervention would be non-inferior to the in-person intervention. Using a randomized comparison trial design, we tested a 10-day brief heart rate variability biofeedback intervention among frontline HCWs during the COVID-19 pandemic. They received remote, 30-min guided sessions every other day and were taught methods of heart rate variability biofeedback. Depression, anxiety and stress were assessed at baseline, 10 days, and 40 days with additional measures of anxiety measured before and after each session. HRV scores were collected at baseline, as well as during the course of the 10 days. Multilevel modelling was used to examine the change in depression, anxiety, stress and HRV scores across multiple time points and session types (telemedicine vs. in-person). There was no significant differences between telemedicine (n = 32) and in-person (n = 15) interventions on the main outcomes. Both session types showed a significant decrease in depression, anxiety and stress scores across the entire intervention, and HRV scores significantly increased across both groups. Anxiety levels also significantly decreased after each session. The non-inferiority of the telemedicine intervention to a comparable in-person intervention affirms its promise for decreasing anxiety, depression and stress among frontline HCWs and may offer a cost-effective and feasible tool to use in crises situations.
在新冠疫情期间,一线医护人员的心理压力有所增加,心理健康风险也随之上升。心率变异性生物反馈(HRV-BF)是一种基于证据的干预措施,有可能减轻一线医护人员的心理负担;然而,自疫情开始以来,尚无研究考察过该措施在这一人群中的应用情况。我们设计了一项试验,旨在评估通过远程医疗提供的简短HRV-BF干预措施对焦虑、抑郁和压力指标以及心率变异性的影响,并与面对面干预进行比较。我们假设远程医疗干预不会比面对面干预效果差。采用随机对照试验设计,我们在新冠疫情期间对一线医护人员进行了为期10天的简短心率变异性生物反馈干预测试。他们每隔一天接受一次30分钟的远程指导课程,并学习心率变异性生物反馈方法。在基线、第10天和第40天评估抑郁、焦虑和压力情况,每次课程前后还会额外评估焦虑情况。在基线以及10天疗程中收集HRV分数。采用多水平模型来考察抑郁、焦虑、压力和HRV分数在多个时间点和课程类型(远程医疗与面对面)上的变化。在主要结局方面,远程医疗组(n = 32)和面对面组(n = 15)的干预措施没有显著差异。两种课程类型在整个干预过程中抑郁、焦虑和压力分数均显著下降,两组的HRV分数均显著增加。每次课程后焦虑水平也显著下降。远程医疗干预与类似的面对面干预效果相当,这证实了其在减轻一线医护人员焦虑、抑郁和压力方面的前景,并且可能为危机情况下提供一种经济有效且可行的工具。